Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Discussion Genetic fusion of protein-based drugs to the N-terminal or C-terminal end of albumin, or both, offers a feasible and attractive approach to enhance the PK properties and therapeutic efficacy of short-lived biologics 6,7
Advances in peptide chemistry and analytical technologies enabled detailed investigation of peptide-mediated communication pathways and molecular regulatory mechanisms
Freezing can denature the peptide and destroy its biological activity entirely
Phenotypic assessment of PZQ activity on NTS About 200 NTS incubated at 37 C in a 5% CO 2 incubator overnight were exposed to different concentrations of PZQ (1, 5, 10, 20, 30, 40 and 50 M) and control without treatment for 24 h in triplicate
US$ 24.53
US$ 23.29
US$ 20.36
US$ 29.15
US$ 28.12
US$ 21.36
US$ 22.74
US$ 26.74
US$ 25.85
